199 related articles for article (PubMed ID: 18558558)
1. Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.
Steininger C; Graninger W; Zoufaly A; Zöllner B; Feucht HH; Kundi M; Stahmer I; Stellbrink HJ; van Lunzen J
Eur J Med Res; 2008 Jun; 13(6):304-8. PubMed ID: 18558558
[TBL] [Abstract][Full Text] [Related]
2. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
3. Examination of serum amyloid A protein in kidney transplant patients--comparison of serum amyloid A and C-reactive protein for monitoring the occurrence of renal-allograft-related complications.
Fukuda Y; Kanbe M; Sumimoto R; Yoneya T; Takeshita T; Hoshino S; Shintaku S; Dohi K
Hiroshima J Med Sci; 1998 Jun; 47(2):63-7. PubMed ID: 9674342
[TBL] [Abstract][Full Text] [Related]
4. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
7. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
[TBL] [Abstract][Full Text] [Related]
9. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients.
Sadeghi M; Daniel V; Naujokat C; Schnitzler P; Schmidt J; Mehrabi A; Zeier M; Opelz G
Transplantation; 2008 Jul; 86(2):275-85. PubMed ID: 18645491
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
[TBL] [Abstract][Full Text] [Related]
12. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).
Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T
J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299
[TBL] [Abstract][Full Text] [Related]
14. The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy.
Fernandez S; Stone SF; Price P; French MA
Clin Immunol; 2008 Aug; 128(2):228-37. PubMed ID: 18511344
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation.
Wu TL; I Chen Tsai ; Chang PY; Tsao KC; Sun CF; Wu LL; Wu JT
Clin Chim Acta; 2007 Feb; 376(1-2):72-6. PubMed ID: 16916504
[TBL] [Abstract][Full Text] [Related]
16. [Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein].
Shimetani N; Ichikawa K; Hachimura K; Tanaka T; Ohtani S; Kanoh Y; Ohtani H
Rinsho Byori; 1996 Jul; 44(7):669-75. PubMed ID: 8741497
[TBL] [Abstract][Full Text] [Related]
17. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
19. Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women.
Mostad SB; Kreiss JK; Ryncarz AJ; Overbaugh J; Mandaliya K; Chohan B; Ndinya-Achola J; Bwayo JJ; Corey L
J Med Virol; 1999 Dec; 59(4):469-73. PubMed ID: 10534728
[TBL] [Abstract][Full Text] [Related]
20. The potential role of C-reactive protein in distinguishing cytomegalovirus from tuberculosis and bacterial infections in renal transplant recipients.
Costalonga EC; Melo NC; Rodrigues CE; Sette LH; Ianhez LE
Clin Transplant; 2009; 23(5):710-5. PubMed ID: 19594772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
